Cargando…
Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway
BACKGROUND AND PURPOSE: It has been accepted that AMPK (Adenosine monophosphate–activated protein kinase) activation exhibits many beneficial effects on glucolipid metabolism. Lysophosphatidylcholine (LPC) is an important lysophospholipid which can improve blood glucose levels in diabetic mice and a...
Autores principales: | Fang, Ru, Zhu, Xudong, Zhu, Yaqin, Tong, Xing, Li, Kexue, Bai, Hui, Li, Xiaoyu, Ben, Jingjing, Zhang, Hanwen, Yang, Qing, Chen, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5040442/ https://www.ncbi.nlm.nih.gov/pubmed/27681040 http://dx.doi.org/10.1371/journal.pone.0163667 |
Ejemplares similares
-
Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway
por: Jiang, Bin, et al.
Publicado: (2022) -
Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021) -
MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis
por: Hu, Liang-Kai, et al.
Publicado: (2021) -
MicroRNA-506-3p targets SIRT1 and suppresses AMPK pathway activation to promote hepatic steatosis
por: Hu, Liang-Kai, et al.
Publicado: (2022) -
Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)